Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WOTAIchem, officially Shandong Wotai Chemical Co., Ltd., is a prominent Chinese chemical manufacturer specializing in cellulose ethers and redispersible polymer powders. The company serves the life sciences sector by producing pharmaceutical-grade Hydroxypropyl Methylcellulose (HPMC), a critical excipient used in the formulation of hard capsules and controlled-release drug delivery systems. WOTAIchem operates large-scale, advanced manufacturing facilities that ensure high purity and consistency for global pharmaceutical and nutraceutical clients. Their product portfolio also includes other cellulose derivatives like HEC and MHEC, supporting a wide range of industrial and healthcare applications. The company is recognized for its robust export capabilities and technical support in polymer chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WOTAIchem.